Author Search Results

1

From modules to medicine How modular domains and their associated networks can enable personalized medicine by Haura, Eric B.

Published 2012

Get full text Get full text Get full text
Text

Save to List

Saved in:
2

Deploying Ibrutinib to Lung Cancer: Another Step in the Quest Towards Drug Repurposing by Haura, Eric B., Rix, Uwe

Published 2014

Get full text Get full text Get full text
Text

Save to List

Saved in:
3

Bidirectional Adaptive Signaling between cancer and stromal cells: Mechanisms and Therapeutics by Boutchueng-Djidjou, M., Rix, Uwe, Haura, Eric B.

Published 2018

Get full text Get full text Get full text
Text

Save to List

Saved in:
4

CAR-T cells and combination therapies: what’s next in the immunotherapy revolution? by Ramello, Maria C., Haura, Eric B., Abate-Daga, Daniel

Published 2017

Get full text Get full text Get full text
Text

Save to List

Saved in:
5

JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer cells and IL-6 Neutralizing Antibodies can Suppress JAK1-STAT3 Signaling by Song, Lanxi, Rawal, Bhupendra, Nemeth, Jeffrey A., Haura, Eric B.

Published 2011

Get full text Get full text Get full text
Text

Save to List

Saved in:
6

CANCER IMMUNOLOGY AT THE CROSSROADS: FUNCTIONAL PROTEOMICS: Charting immune signaling proteomes en route to new therapeutic strategies by Haura, Eric B., Beg, Amer A., Rix, Uwe, Antonia, Scott

Published 2015

Get full text Get full text Get full text
Text

Save to List

Saved in:
7

A pilot study of preoperative gefitinib for early stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance by Haura, Eric B., Sommers, Eric, Song, Lanxi, Chiappori, Alberto, Becker, Aaron

Published 2010

Get full text Get full text Get full text
Text

Save to List

Saved in:
8

Methods for Investigation of Targeted Kinase Inhibitor Therapy using Chemical Proteomics and Phosphorylation Profiling by Fang, Bin, Haura, Eric B., Smalley, Keiran S., Eschrich, Steven A., Koomen, John M.

Published 2010

Get full text Get full text Get full text
Text

Save to List

Saved in:
9

Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer by Hoffman, Melissa A., Fang, Bin, Haura, Eric B., Rix, Uwe, Koomen, John M.

Published 2017

Get full text Get full text Get full text
Text

Save to List

Saved in:
10

Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells by Gao, Jingchun, Zheng, Zhong, Rawal, Bhupendra, Schell, Michael J., Bepler, Gerold, Haura, Eric B.

Published 2009

Get full text Get full text
Text

Save to List

Saved in:
11

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors by Balko, Justin M, Potti, Anil, Saunders, Christopher, Stromberg, Arnold, Haura, Eric B, Black, Esther P

Published 2006

Get full text Get full text Get full text
Text

Save to List

Saved in:
12

Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit by Xiong, Hairong, Lee, Robert J., Haura, Eric B., Edwards, John G., Dynan, William S., Li, Shuyi

Published 2011

Get full text Get full text Get full text
Text

Save to List

Saved in:
13

The NAD(+) Synthesis Enzyme Nicotinamide Mononucleotide Adenylyltransferase (NMNAT1) Regulates Ribosomal RNA Transcription by Song, Tanjing, Yang, Leixiang, Kabra, Neha, Chen, Lihong, Koomen, John, Haura, Eric B., Chen, Jiandong

Published 2013

Get full text Get full text Get full text
Text

Save to List

Saved in:
14

Cell signaling heterogeneity is modulated by both cell-intrinsic and -extrinsic mechanisms: An integrated approach to understanding targeted therapy by Kim, Eunjung, Kim, Jae-Young, Smith, Matthew A., Haura, Eric B., Anderson, Alexander R. A.

Published 2018

Get full text Get full text Get full text
Text

Save to List

Saved in:
15

Synthesis and Structural Characterization of a Monocarboxylic Inhibitor for GRB2 SH2 Domain by Xiao, Tao, Sun, Luxin, Zhang, Min, Li, Zilu, Haura, Eric B., Schonbrunn, Ernst, Ji, Haitao

Published 2021

Get full text Get full text Get full text
Text

Save to List

Saved in:
16

Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling by Machida, Kazuya, Eschrich, Steven, Li, Jiannong, Bai, Yun, Koomen, John, Mayer, Bruce J., Haura, Eric B.

Published 2010

Get full text Get full text Get full text
Text

Save to List

Saved in:
17

An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation by Tang, Huifang, Yan, Chunguang, Cao, Jay, Sarma, J. Vidya, Haura, Eric B., Wu, Min, Gao, Hongwei

Published 2011

Get full text Get full text Get full text
Text

Save to List

Saved in:
18

Curcumin: A Novel Stat 3 Pathway Inhibitor for Chemoprevention of Lung Cancer by Alexandrow, Mark G., Song, Lanxi J., Altiok, Soner, Gray, Jhanelle, Haura, Eric B., Kumar, Nagi B.

Published 2012

Get full text Get full text Get full text
Text

Save to List

Saved in:
19

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer by Song, Lanxi, Smith, Matthew A., Doshi, Parul, Sasser, Kate, Fulp, William, Altiok, Soner, Haura, Eric B.

Published 2014

Get full text Get full text Get full text
Text

Save to List

Saved in:
20

Using iTRAQ(®) Combined with Tandem Affinity Purification to Enhance Low-abundance Proteins Associated with Somatically-mutated EGFR Core Complexes in Lung Cancer by Haura, Eric B., Müller, André, Brietwieser, Florian P., Li, Jiannong, Grebien, Florian, Colinge, Jacques, Bennett, Keiryn L.

Published 2010

Get full text Get full text Get full text
Text

Save to List

Saved in:

Search Results - Haura, Eric B.

From modules to medicine How modular domains and their associated networks can enable personalized medicine by Haura, Eric B.

Deploying Ibrutinib to Lung Cancer: Another Step in the Quest Towards Drug Repurposing by Haura, Eric B., Rix, Uwe

Bidirectional Adaptive Signaling between cancer and stromal cells: Mechanisms and Therapeutics by Boutchueng-Djidjou, M., Rix, Uwe, Haura, Eric B.

CAR-T cells and combination therapies: what’s next in the immunotherapy revolution? by Ramello, Maria C., Haura, Eric B., Abate-Daga, Daniel

JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer cells and IL-6 Neutralizing Antibodies can Suppress JAK1-STAT3 Signaling by Song, Lanxi, Rawal, Bhupendra, Nemeth, Jeffrey A., Haura, Eric B.

CANCER IMMUNOLOGY AT THE CROSSROADS: FUNCTIONAL PROTEOMICS: Charting immune signaling proteomes en route to new therapeutic strategies by Haura, Eric B., Beg, Amer A., Rix, Uwe, Antonia, Scott

A pilot study of preoperative gefitinib for early stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance by Haura, Eric B., Sommers, Eric, Song, Lanxi, Chiappori, Alberto, Becker, Aaron

Methods for Investigation of Targeted Kinase Inhibitor Therapy using Chemical Proteomics and Phosphorylation Profiling by Fang, Bin, Haura, Eric B., Smalley, Keiran S., Eschrich, Steven A., Koomen, John M.

Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer by Hoffman, Melissa A., Fang, Bin, Haura, Eric B., Rix, Uwe, Koomen, John M.

Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells by Gao, Jingchun, Zheng, Zhong, Rawal, Bhupendra, Schell, Michael J., Bepler, Gerold, Haura, Eric B.

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors by Balko, Justin M, Potti, Anil, Saunders, Christopher, Stromberg, Arnold, Haura, Eric B, Black, Esther P

Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit by Xiong, Hairong, Lee, Robert J., Haura, Eric B., Edwards, John G., Dynan, William S., Li, Shuyi

The NAD(+) Synthesis Enzyme Nicotinamide Mononucleotide Adenylyltransferase (NMNAT1) Regulates Ribosomal RNA Transcription by Song, Tanjing, Yang, Leixiang, Kabra, Neha, Chen, Lihong, Koomen, John, Haura, Eric B., Chen, Jiandong

Cell signaling heterogeneity is modulated by both cell-intrinsic and -extrinsic mechanisms: An integrated approach to understanding targeted therapy by Kim, Eunjung, Kim, Jae-Young, Smith, Matthew A., Haura, Eric B., Anderson, Alexander R. A.

Synthesis and Structural Characterization of a Monocarboxylic Inhibitor for GRB2 SH2 Domain by Xiao, Tao, Sun, Luxin, Zhang, Min, Li, Zilu, Haura, Eric B., Schonbrunn, Ernst, Ji, Haitao

Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling by Machida, Kazuya, Eschrich, Steven, Li, Jiannong, Bai, Yun, Koomen, John, Mayer, Bruce J., Haura, Eric B.

An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation by Tang, Huifang, Yan, Chunguang, Cao, Jay, Sarma, J. Vidya, Haura, Eric B., Wu, Min, Gao, Hongwei

Curcumin: A Novel Stat 3 Pathway Inhibitor for Chemoprevention of Lung Cancer by Alexandrow, Mark G., Song, Lanxi J., Altiok, Soner, Gray, Jhanelle, Haura, Eric B., Kumar, Nagi B.

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer by Song, Lanxi, Smith, Matthew A., Doshi, Parul, Sasser, Kate, Fulp, William, Altiok, Soner, Haura, Eric B.

Using iTRAQ(®) Combined with Tandem Affinity Purification to Enhance Low-abundance Proteins Associated with Somatically-mutated EGFR Core Complexes in Lung Cancer by Haura, Eric B., Müller, André, Brietwieser, Florian P., Li, Jiannong, Grebien, Florian, Colinge, Jacques, Bennett, Keiryn L.

Search Tools: